The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014 as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Grant of Covenant Waiver and Covenant Reset
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in-class, specialist neonatal intensive care medical devices, announces that the Company's lender, HSBC, has granted a waiver in respect of the EBITDA covenant for the 31 October 2024 test date and a reset of such covenant at a lower level for the 31 January 2025 test date. The interest cover and net leverage covenants have also been reset for the period through to 31 January 2026. The requirement for the waiver and reset of the covenants is a result of the previously announced trading conditions noted in the Group's interim results.
In addition, the Company's lender will allow drawdowns on the Revolving Credit Facility ("RCF") up to
For further information, please contact:
Inspiration Healthcare Group plc |
Tel: +44 (0)330 175 0000 |
Roy Davis, Executive Chair and Interim CEO Alan Olby, Chief Financial Officer |
|
|
|
Panmure Liberum (Nominated Adviser & Broker) |
Tel: +44 (0)20 3100 2000 |
Richard Lindley Will King |
|
|
|
Walbrook PR Ltd (Media and Investor Relations) |
Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com |
Anna Dunphy |
Mob: +44 (0) 7876 741 001 |
Louis Ashe-Jepson |
Mob: +44 (0) 7747 515 393 |
|
|
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the
The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.
The Company sells its products directly to hospitals and healthcare providers in the
The Company operates in the
Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.